BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16532656)

  • 1. [Molecular biological basis of the gonococcal pathogenicity and specific features of immune response].
    Kostiukova NN; Bekhalo VA
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (1):105-12. PubMed ID: 16532656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology of the Gonococcus: Disease and Pathogenesis.
    Shaughnessy J; Ram S; Rice PA
    Methods Mol Biol; 2019; 1997():1-27. PubMed ID: 31119614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gonococcal surface antigens and their significance for serotyping and vaccines].
    Kohl PK; Meyer TF; Petzoldt D
    Hautarzt; 1985 Jun; 36(6):320-5. PubMed ID: 2862130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase and antigenic variation of pili and outer membrane protein II of Neisseria gonorrhoeae.
    Sparling PF; Cannon JG; So M
    J Infect Dis; 1986 Feb; 153(2):196-201. PubMed ID: 2418125
    [No Abstract]   [Full Text] [Related]  

  • 5. The sixth C. L. Oakley lecture. Molecular studies on the pathogenesis of gonorrhoea.
    Heckels JE
    J Med Microbiol; 1984 Dec; 18(3):293-307. PubMed ID: 6209398
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential response of human monocytes to Neisseria gonorrhoeae variants expressing pili and opacity proteins.
    Knepper B; Heuer I; Meyer TF; van Putten JP
    Infect Immun; 1997 Oct; 65(10):4122-9. PubMed ID: 9317017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple gonococcal pilin antigenic variants are produced during experimental human infections.
    Seifert HS; Wright CJ; Jerse AE; Cohen MS; Cannon JG
    J Clin Invest; 1994 Jun; 93(6):2744-9. PubMed ID: 7911129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of two novel Neisseria gonorrhoeae virulent components: the macrophage infectivity potentiator and the outer membrane protein A.
    Starnino S; Leuzzi R; Ghisetti V; De Francesco MA; Cusini M; Impara G; Galluppi E; Pizza M; Stefanelli P
    New Microbiol; 2010 Apr; 33(2):167-70. PubMed ID: 20518279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potential role for the major iron-regulated protein expressed by pathogenic Neisseria species.
    Morse SA; Chen CY; LeFaou A; Mietzner TA
    Rev Infect Dis; 1988; 10 Suppl 2():S306-10. PubMed ID: 3142015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase variation leads to the misidentification of a Neisseria gonorrhoeae virulence gene.
    Anderson MT; Seifert HS
    PLoS One; 2013; 8(8):e72183. PubMed ID: 23977246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Questions about gonococcal pilus phase- and antigenic variation.
    Seifert HS
    Mol Microbiol; 1996 Aug; 21(3):433-40. PubMed ID: 8866467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against infection with Neisseria gonorrhoeae by immunization with outer membrane protein complex and purified pili.
    Buchanan TM; Pearce WA; Schoolnik GK; Arko RJ
    J Infect Dis; 1977 Aug; 136 Suppl():S132-7. PubMed ID: 408428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular bases of virulence in Neisseria gonorrhoeae].
    Marchal C; Taha MK; Larribe M; Seifert HS; So M
    Bull Acad Natl Med; 1991; 175(6):823-34. PubMed ID: 1683810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neisseria gonorrhoeae metalloprotease NGO1686 is required for full piliation, and piliation is required for resistance to H2O2- and neutrophil-mediated killing.
    Stohl EA; Dale EM; Criss AK; Seifert HS
    mBio; 2013 Jul; 4(4):. PubMed ID: 23839218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neisseria gonorrhoeae elicits extracellular traps in primary neutrophil culture while suppressing the oxidative burst.
    Gunderson CW; Seifert HS
    mBio; 2015 Feb; 6(1):. PubMed ID: 25670773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonococcal salpingitis is less likely to recur with Neisseria gonorrhoeae of the same principal outer membrane protein antigenic type.
    Buchanan TM; Eschenbach DA; Knapp JS; Holmes KK
    Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 2):978-80. PubMed ID: 6781350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic variation. Modulating bacterial virulence.
    Saunders JR
    Nature; 1989 Apr; 338(6217):622-3. PubMed ID: 2565019
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.
    Marjuki H; Topaz N; Joseph SJ; Gernert KM; Kersh EN; ; Wang X
    mBio; 2019 Sep; 10(5):. PubMed ID: 31506309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine.
    Gulati S; Shaughnessy J; Ram S; Rice PA
    Front Immunol; 2019; 10():321. PubMed ID: 30873172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental human gonococcal urethritis: 250 Neisseria gonorrhoeae MS11mkC are infective.
    Schneider H; Cross AS; Kuschner RA; Taylor DN; Sadoff JC; Boslego JW; Deal CD
    J Infect Dis; 1995 Jul; 172(1):180-5. PubMed ID: 7797908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.